Validated antibody with 51 RRID-verified research citations across 2 targets. Confirmed for FC. Reactive in Porcine, Mouse.

CD117 (c-Kit) Monoclonal Antibody (2B8), APC-eFluor™ 780, eBioscience

Thermo Fisher ScientificCat# 47-1171-82Clone: Clone 2B8
51citations
Applications
FC
Reactivity
PorcineMouse
HostRat
ClonalityMonoclonal
Research Usage51citations
View on Thermo Fisher ScientificView RRID verification

More CD47 antibodies from other suppliers

Compared on specifications and validation. No paid placements.

CD47 (Magrolimab) Recombinant Monoclonal Antibody
CUSABIOCat# CSB-RA004940MA1HUClone: 4E5
Validated · ELISA, FC
Applications
ELISAFC
Reactivity
Human
Host
ClonalityMonoclonal
View datasheet on CUSABIO
CD47 Antibody
CUSABIOCat# CSB-PA005993
Validated · WB, ELISA
Applications
WBELISA
Reactivity
Human
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
CD47 Antibody
CUSABIOCat# CSB-PA445679
Validated · ELISA, WB, IHC
Applications
ELISAWBIHC
Reactivity
Human
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
CD47 Antibody
CUSABIOCat# CSB-PA911004
Validated · ELISA, IHC
Applications
ELISAIHC
Reactivity
Human
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
CD47 Antibody
CUSABIOCat# CSB-PA004940LA01HU
Validated · ELISA, IHC, IF
Applications
ELISAIHCIF
Reactivity
Human
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
CD47 Recombinant Monoclonal Antibody
CUSABIOCat# CSB-RA802124A0HUClone: 4G11
Validated · ELISA, WB, IHC
Applications
ELISAWBIHCIF
Reactivity
Human
HostRabbit
ClonalityMonoclonal
View datasheet on CUSABIO
Anti-CD47 (Extracellular region) Antibody
OriGeneCat# TA389097Clone: M054
Datasheet specs
Applications
ICCIPWB
Reactivity
Human
HostMouse
Clonality
View datasheet on OriGene
Datasheet specs
Applications
ELISAFC
Reactivity
Human
HostHuman
ClonalityMonoclonal
View datasheet on OriGene

+ 37 more CD47 options from other suppliers.

Product verified through the Antibody Registry (RRID). Application and species data from supplier specifications and published research. No paid placements.